Home > Financial Ratios > GLAND PHARMA

GLAND PHARMA
Net Sales Growth

    Back to All Ratios
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Sales Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Net Sales Growth(%) 14.50-0.8556.29-17.6427.08

What is the latest Net Sales Growth ratio of GLAND PHARMA ?

The latest Net Sales Growth ratio of GLAND PHARMA is 14.50 based on Mar2026 Consolidated results.
Year Net Sales Growth
Mar202614.50
Mar2025-0.85
Mar202456.29
Mar2023-17.64
Mar202227.08

How is Net Sales Growth of GLAND PHARMA Trending?

Years Net Sales Growth % Change
Mar2026 14.5
Positive
Mar2025 -0.85
Negative
Mar2024 56.29
Positive
Mar2023 -17.64
Negative
Mar2022 27.08 -

Other Financial Ratios of GLAND PHARMA


Compare Net Sales Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹43,947.8 Cr 3.2% 7.4% 31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,530.0 Cr -0.4% 0.9% 19.6% Stock Analytics
DIVIS LABORATORIES ₹219,675.0 Cr -1.2% 21.1% 29.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,970.0 Cr -2.3% 0.3% 34.8% Stock Analytics
CIPLA ₹117,947.0 Cr 0.7% 1.5% -2% Stock Analytics
DR REDDYS LABORATORIES ₹96,601.2 Cr -0.3% -7.1% -3.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.2%

7.4%

31.4%

SENSEX

-0.1%

2.4%

-3.3%


You may also like the below Video Courses